DNA analysis is becoming routine in the clinical laboratory for the diagnos
is of human diseases using various tissue sources. Most clinical specimens
are followed by tracking forms that include patient demographic data, acces
sion number, and date and time of collection. As part of a thorough quality
assurance program, proper documentation of test requisitions and tracking
forms is mandatory. Despite these efforts, specimen mislabeling or other mi
x-ups can, and do, occur. We demonstrate the utility of the PM+DQA1 typing
kit and STR analysis using the Visible Genetics automated DNA sequencing sy
stem in the proper identification of such clinical specimens as urine, bloo
d, and paraffin-embedded tissues. In each case, sufficient DNA was extracte
d from these specimen types using a nonorganic extraction protocol for typi
ng purposes. We conclude that DNA typing methods are feasible for distingui
shing clinical laboratory specimens of questionable identity and compliment
existing quality assurance techniques.